NCT05958537View on ClinicalTrials.gov

High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers

NACompletedINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

Aortic StenosisSedation Complication

Interventions

DEVICE

High flow nasal oxygen

Use of High-flow nasal oxygen at 60% 50 L/min.

Trial Locations (1)

08036

Hospital Clínic Barcelona, Barcelona

All Listed Sponsors

lead

Hospital Clinic of Barcelona

OTHER

NCT05958537 - High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers | Biotech Hunter | Biotech Hunter